2023 - Research.com Medicine in Canada Leader Award
2023 - Research.com Biology and Biochemistry in Canada Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Biology and Biochemistry in Canada Leader Award
2014 - Wittgenstein Award
2011 - Fellow of the American Association for the Advancement of Science (AAAS)
2009 - Member of Academia Europaea
2004 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Microbiology and Immunology
Member of the European Academy of Sciences and Arts
Member of the European Molecular Biology Organization (EMBO)
Josef M. Penninger mainly focuses on Cell biology, Immunology, Signal transduction, Molecular biology and Apoptosis. His Cell biology research is multidisciplinary, incorporating perspectives in T cell, T-cell receptor, Apoptosis-inducing factor and Programmed cell death. His Autoimmunity, Innate immune system and Antigen study in the realm of Immunology connects with subjects such as Angiotensin-converting enzyme 2.
His Signal transduction study combines topics from a wide range of disciplines, such as CD28 and Kinase, Protein kinase A. Josef M. Penninger combines subjects such as Cell culture, Cytochrome c, Stem cell, Cytotoxic T cell and DNA fragmentation with his study of Molecular biology. His study on PTEN also encompasses disciplines like
His primary areas of study are Cell biology, Internal medicine, Immunology, Endocrinology and Cancer research. His Cell biology research includes elements of T cell, T-cell receptor and Programmed cell death. His study in the field of RANKL, Angiotensin II and Receptor also crosses realms of Angiotensin-converting enzyme 2.
Josef M. Penninger works mostly in the field of RANKL, limiting it down to topics relating to Osteoclast and, in certain cases, Bone resorption, as a part of the same area of interest. His Myocarditis research extends to the thematically linked field of Immunology. His research integrates issues of Carcinogenesis, Cancer and Protein kinase B in his study of Cancer research.
His main research concerns Cell biology, Internal medicine, Endocrinology, Cancer research and RANKL. His Cell biology research incorporates elements of Inflammation, Cell and Ubiquitin ligase. His studies in Internal medicine integrate themes in fields like Pregnancy and Cardiology.
In his study, which falls under the umbrella issue of Endocrinology, Renin–angiotensin system, Pharmacology and Kidney is strongly linked to Receptor. His Cancer research study combines topics in areas such as Carcinogenesis, Cancer, Immune system, Signal transduction and Lung cancer. His RANKL research focuses on Osteoclast and how it connects with Bone resorption and Activator.
Internal medicine, Cell biology, Cancer research, Receptor and Endocrinology are his primary areas of study. In Internal medicine, Josef M. Penninger works on issues like Cardiology, which are connected to Regeneration, Ligation and Genome-wide association study. Particularly relevant to Signal transduction is his body of work in Cell biology.
His Cancer research study integrates concerns from other disciplines, such as Cancer, ErbB, Lung cancer and In vivo. His studies deal with areas such as Immunology, Stromal cell and Bone remodeling as well as Receptor. His Endocrinology research includes themes of Osteoclast, AMPK, Starvation response and RANKL.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Daniel J. Klionsky;Kotb Abdelmohsen;Akihisa Abe;Joynal Abedin.
Molecular characterization of mitochondrial apoptosis-inducing factor
Santos A. Susin;Hans K. Lorenzo;Naoufal Zamzami;Isabel Marzo.
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
Young-Yun Kong;Hiroki Yoshida;Ildiko Sarosi;Hong-Lin Tan.
Cerebral organoids model human brain development and microcephaly
Madeline A. Lancaster;Magdalena Renner;Carol Anne Martin;Daniel Wenzel.
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Keiji Kuba;Yumiko Imai;Shuan Rao;Hong Gao.
Nature Medicine (2005)
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Paul Waterhouse;Josef M. Penninger;Emma Timms;Andrew Wakeham.
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
Vuk Stambolic;Vuk Stambolic;Akira Suzuki;Akira Suzuki;José Luis de la Pompa;José Luis de la Pompa.
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Yumiko Imai;Keiji Kuba;Shuan Rao;Yi Huan.
Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target.
Haibo Zhang;Haibo Zhang;Haibo Zhang;Josef M. Penninger;Josef M. Penninger;Yimin Li;Nanshan Zhong.
Intensive Care Medicine (2020)
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
Young-Yun Kong;Ulrich Feige;Iidiko Sarosi;Brad Bolon.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: